Health Care • Medical/Nursing Services
$9.24 ▲ +0.14
(+1.54%)
MKT CAP: $1.26B • VOL: 585.6K
52W L $4 52W H $13
INNV // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $853.7M | $763.9M | $688.1M |
| YoY Revenue Growth % | +11.8% | +11.0% | — |
| Gross Profit | $153.6M | $132.1M | — |
| Gross Margin % | 18.0% | 17.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$29.8M | -$23.2M | -$49.4M |
| Operating Margin % | -3.5% | -3.0% | -7.2% |
| Net Income (GAAP) | -$30.3M | -$21.3M | -$40.7M |
| EBITDA (Normalized) | -$24.8M | -$16.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $32.9M | -$36.9M | $20.2M |
| Capital Expenditures (CapEx) | $6.3M | $7.9M | — |
| Free Cash Flow (FCF) | $26.6M | -$44.8M | $20.2M |
| FCF Margin % | 3.1% | -5.9% | 2.9% |
| Return on Invested Capital (ROIC %) | -10.2% | -7.0% | — |
| Cash & Short-Term Equivalents | $83.2M | $46.1M | — |
| Total Debt (Short + Long Term) | $56.0M | $59.8M | — |
| Total Stockholders' Equity | $256.8M | $248.5M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR INNV.